Iordache Diana, Kövendi Anita-Andrea, Fekete Zsolt, Popița Raluca, Cebotaru Iunia Patricia, Patka Annamaria, Năstase Ioana Cristina, Cebotaru Cristina Ligia
"Iuliu Hațieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Institute of Oncology "Prof Dr. Ion Chiricuță", Cluj-Napoca, Romania.
Case Rep Oncol. 2024 Sep 4;17(1):988-994. doi: 10.1159/000540084. eCollection 2024 Jan-Dec.
Clear cell sarcoma (CCS) of soft tissue is a rare type of soft tissue sarcoma affecting usually lower extremities in young adults. The main challenges in the management of this disease include difficulties in diagnosis, aggressiveness of the cancer with rapid progression, and inadequate treatment, especially in small centers with few cases.
We present a case of a young woman diagnosed with CCS of soft tissue, stage IV. The patient benefited from a multidisciplinary approach including radiation therapy, surgery, chemotherapy, and targeted therapy with disease progression regardless of the therapeutic act. Despite all the efforts, the patient died from complications overlapping progression of the disease.
The rarity of this sarcoma limits the amount of information available on the diagnosis and treatment process. The particularity of this case is the difficulty met in maintaining the disease under control using all the resources available due to lack of compliance of the patient in carrying out amputation at diagnosis, thus modifying the entire treatment algorithm. Targeted therapy showed promising results in the literature, however in our case resulted in an unexpected, rare adverse event aggravating the patient's condition. In conclusion, patients with CCS should be referred to specialized centers for adequate multidisciplinary management and, if available, inclusion in clinical trials. New agents are needed to improve the survival of these patients.
软组织透明细胞肉瘤(CCS)是一种罕见的软组织肉瘤类型,通常影响年轻成年人的下肢。该疾病管理中的主要挑战包括诊断困难、癌症侵袭性强且进展迅速以及治疗不足,尤其是在病例较少的小中心。
我们报告一例诊断为IV期软组织CCS的年轻女性病例。患者受益于多学科方法,包括放疗、手术、化疗和靶向治疗,但无论采取何种治疗措施,疾病仍进展。尽管付出了所有努力,患者最终死于与疾病进展重叠的并发症。
这种肉瘤的罕见性限制了有关诊断和治疗过程的可用信息量。该病例的特殊性在于,由于患者在诊断时不配合截肢,导致难以利用所有可用资源控制疾病,从而改变了整个治疗方案。靶向治疗在文献中显示出有前景的结果,但在我们的病例中却导致了意想不到的罕见不良事件,加重了患者的病情。总之,CCS患者应转诊至专业中心进行充分的多学科管理,如有可能,应纳入临床试验。需要新的药物来提高这些患者的生存率。